Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of dimethyl fumarate enteric capsules (百特欣®) in relapsing multiple sclerosis
CTR20251580Phase 4Active
- Sponsor
- Sichuan Hongmingbosi Pharmaceutical
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Sichuan Hongmingbosi Pharmaceutical. Started Aug 2025; status: active.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20251580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251580.